Raymond James Financial Inc. Acquires New Shares in Alpha Teknova, Inc. (NASDAQ:TKNO)

Raymond James Financial Inc. bought a new position in Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 85,779 shares of the company's stock, valued at approximately $716,000. Raymond James Financial Inc. owned about 0.16% of Alpha Teknova at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its position in Alpha Teknova by 622.5% during the fourth quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock valued at $37,000 after buying an additional 3,791 shares during the period. Mount Lucas Management LP acquired a new stake in shares of Alpha Teknova during the 4th quarter valued at about $75,000. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Alpha Teknova during the 4th quarter valued at about $94,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new stake in shares of Alpha Teknova during the 4th quarter valued at about $180,000. Finally, Whalen Wealth Management Inc. acquired a new stake in shares of Alpha Teknova during the 4th quarter valued at about $240,000. 13.81% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Craig Hallum initiated coverage on Alpha Teknova in a research report on Monday, February 10th. They set a "buy" rating and a $12.00 target price on the stock.

Alpha Teknova Price Performance

TKNO stock traded up $0.04 during trading on Monday, hitting $7.00. The stock had a trading volume of 48,218 shares, compared to its average volume of 379,810. The company has a debt-to-equity ratio of 0.12, a current ratio of 4.73 and a quick ratio of 3.94. Alpha Teknova, Inc. has a twelve month low of $1.16 and a twelve month high of $10.37. The stock has a market capitalization of $374.14 million, a P/E ratio of -9.38 and a beta of 0.50. The company's 50-day moving average price is $5.76 and its two-hundred day moving average price is $7.11.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.02. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The company had revenue of $9.60 million for the quarter, compared to analysts' expectations of $9.41 million. As a group, research analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.